Jones M - Search Results

1

Isosorbide-2-benzyl carbamate-5-salicylate, a peripheral anionic site binding subnanomolar selective butyrylcholinesterase inhibitor.

Carolan CG, Dillon GP, Khan D, Ryder SA, Gaynor JM, Reidy S, Marquez JF, Jones M, Holland V, Gilmer JF. Carolan CG, et al. Among authors: jones m. J Med Chem. 2010 Feb 11;53(3):1190-9. doi: 10.1021/jm9014845. J Med Chem. 2010. PMID: 20067290

2

Discovery of a "true" aspirin prodrug.

Moriarty LM, Lally MN, Carolan CG, Jones M, Clancy JM, Gilmer JF. Moriarty LM, et al. Among authors: jones m. J Med Chem. 2008 Dec 25;51(24):7991-9. doi: 10.1021/jm801094c. J Med Chem. 2008. PMID: 19049433

3

Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groups.

Jones M, Inkielewicz I, Medina C, Santos-Martinez MJ, Radomski A, Radomski MW, Lally MN, Moriarty LM, Gaynor J, Carolan CG, Khan D, O'Byrne P, Harmon S, Holland V, Clancy JM, Gilmer JF. Jones M, et al. J Med Chem. 2009 Nov 12;52(21):6588-98. doi: 10.1021/jm900561s. J Med Chem. 2009. PMID: 19821574

4

Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer's Disease.

Jones M, Wang J, Harmon S, Kling B, Heilmann J, Gilmer JF. Jones M, et al. Molecules. 2016 Apr 1;21(4):440. doi: 10.3390/molecules21040440. Molecules. 2016. PMID: 27534722 Free PMC article.

5

In vivo impact of prodrug isosorbide-5-nicotinate-2-aspirinate on lipids and prostaglandin D2: is this a new immediate-release therapeutic option for niacin?

Ledwidge MT, Ryan F, Kerins DM, O'Connell D, Cefali G, Harmon S, Jones M, Gilmer JF. Ledwidge MT, et al. Among authors: jones m. Atherosclerosis. 2012 Apr;221(2):478-83. doi: 10.1016/j.atherosclerosis.2012.01.016. Epub 2012 Jan 13. Atherosclerosis. 2012. PMID: 22326030

6

Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin.

Medina C, Harmon S, Inkielewicz I, Santos-Martinez MJ, Jones M, Cantwell P, Bazou D, Ledwidge M, Radomski MW, Gilmer JF. Medina C, et al. Among authors: jones m. Br J Pharmacol. 2012 Jun;166(3):938-49. doi: 10.1111/j.1476-5381.2011.01794.x. Br J Pharmacol. 2012. PMID: 22122360 Free PMC article.

7

Mechanisms of aggregation inhibition by aspirin and nitrate-aspirin prodrugs in human platelets.

Harmon S, Inkielewicz-Stepniak I, Jones M, Ledwidge M, Santos-Martinez MJ, Medina C, Radomski MW, Gilmer JF. Harmon S, et al. Among authors: jones m. J Pharm Pharmacol. 2012 Jan;64(1):77-89. doi: 10.1111/j.2042-7158.2011.01380.x. Epub 2011 Nov 10. J Pharm Pharmacol. 2012. PMID: 22150675

8

Response of birds to climatic variability; evidence from the western fringe of Europe.

Donnelly A, Cooney T, Jennings E, Buscardo E, Jones M. Donnelly A, et al. Among authors: jones m. Int J Biometeorol. 2009 May;53(3):211-20. doi: 10.1007/s00484-009-0206-7. Epub 2009 Feb 6. Int J Biometeorol. 2009. PMID: 19198888

9

Evaluating Ireland's IBIA as an approach to improving the quality and effectiveness of biodiversity impact assessment.

González A, Hochstrasser T, Fry J, Scott P, Grist B, Jones M. González A, et al. Among authors: jones m. J Environ Manage. 2013 Dec 15;131:150-60. doi: 10.1016/j.jenvman.2013.09.023. Epub 2013 Oct 24. J Environ Manage. 2013. PMID: 24161804

10

The effect of renovation of long-term temperate grassland on N2O emissions and N leaching from contrasting soils.

Krol DJ, Jones MB, Williams M, Richards KG, Bourdin F, Lanigan GJ. Krol DJ, et al. Among authors: jones mb. Sci Total Environ. 2016 Aug 1;560-561:233-40. doi: 10.1016/j.scitotenv.2016.04.052. Epub 2016 Apr 19. Sci Total Environ. 2016. PMID: 27101460

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13,862 results

Search Page